The earnings call highlighted strong revenue growth and market share gains across key segments, with record earnings and strategic advancements in product offerings. However, challenges with unexpected market softness and specific product revenue declines were noted, alongside ongoing capacity constraints and FX headwinds.

Company Guidance

During the Cooper Companies Fourth Quarter 2024 Earnings Call, the company reported record revenues of $3.9 billion for the fiscal year, with Q4 revenues reaching $1.018 billion, a 10% increase year-over-year. CooperVision's quarterly revenue was $676 million, up 9% organically, while CooperSurgical posted $342 million, a 12% increase. The company expressed confidence in growing faster than the market, forecasting the contact lens market to grow by 5% to 7% in constant currency, with CooperVision expected to grow by 6.5% to 8.5%. Non-GAAP earnings per share increased by 19% to $1.04. Fiscal 2025 guidance indicates consolidated revenues between $4.08 billion and $4.158 billion, with an anticipated operating income growth of 10% to 12% in constant currency. The company also highlighted expected growth in their myopia management business, projecting MiSight to grow around 40% in fiscal 2025.

Record Revenue Achievement

Cooper Companies achieved all-time record revenues of $3.9 billion in fiscal 2024, with both CooperVision and CooperSurgical reporting record revenues.

Strong Performance in CooperVision

CooperVision reported quarterly revenues of $676 million, up 9% or 8% organically, driven by strength in silicone hydrogel dailies and multifocals.

Fertility Segment Growth

CooperSurgical's fertility segment reported quarterly revenues of $139 million, up 15% or 13% organically, with significant market share gains.

Non-GAAP Earnings Growth

Non-GAAP earnings per share grew 19% to $1.04, reflecting strong earnings growth and margin improvements.

Advances in Myopia Management

MiSight fitting activity remained strong with a 24% growth, and CooperVision expects around 40% growth in fiscal 2025.

Commitment to Price Increases and Efficiency

Price increases and efficiency gains led to a slight improvement in gross margins to 66.9%, with operating income up 16.2%.

---

Cooper Co (COO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

COO Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Feb 27, 2025	2025 (Q1)	0.92 / -	0.85	―	―	―
Dec 05, 2024	2024 (Q4)	1.00 / 1.04	0.868	19.82% (+0.17)
Aug 28, 2024	2024 (Q3)	0.91 / 0.96	0.838	14.56% (+0.12)
May 30, 2024	2024 (Q2)	0.83 / 0.85	0.77	10.39% (+0.08)
Feb 29, 2024	2024 (Q1)	0.78 / 0.85	0.725	17.24% (+0.13)	―
Dec 07, 2023	2023 (Q4)	0.87 / 0.87	0.688	26.16% (+0.18)	―
Aug 30, 2023	2023 (Q3)	0.84 / 0.84	0.798	5.01% (+0.04)	―
Jun 01, 2023	2023 (Q2)	0.76 / 0.77	0.81	-4.94% (-0.04)	―
Mar 02, 2023	2023 (Q1)	0.67 / 0.72	0.81	-10.49% (-0.09)	―
Dec 08, 2022	2022 (Q4)	0.78 / 0.69	0.82	-16.10% (-0.13)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

---

COO Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Dec 05, 2024	$103.23	$98.70	-4.39%
Aug 28, 2024	$94.54	$105.73	+11.84%
May 30, 2024	$90.23	$94.31	+4.52%
Feb 29, 2024	$93.60	$102.19	+9.18%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

---